ATE241607T1 - Epoxybernsteinsäureamid-derivate - Google Patents

Epoxybernsteinsäureamid-derivate

Info

Publication number
ATE241607T1
ATE241607T1 AT98941728T AT98941728T ATE241607T1 AT E241607 T1 ATE241607 T1 AT E241607T1 AT 98941728 T AT98941728 T AT 98941728T AT 98941728 T AT98941728 T AT 98941728T AT E241607 T1 ATE241607 T1 AT E241607T1
Authority
AT
Austria
Prior art keywords
alkyl
heterocyclic
group
aryl
aralkyl
Prior art date
Application number
AT98941728T
Other languages
English (en)
Inventor
Yutaka Nomura
Toshihiro Takahashi
Yasushi Yoshino
Koichiro Nishioka
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Application granted granted Critical
Publication of ATE241607T1 publication Critical patent/ATE241607T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT98941728T 1997-09-04 1998-09-04 Epoxybernsteinsäureamid-derivate ATE241607T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25753897 1997-09-04
PCT/JP1998/003983 WO1999011640A1 (en) 1997-09-04 1998-09-04 Epoxysuccinamide derivatives

Publications (1)

Publication Number Publication Date
ATE241607T1 true ATE241607T1 (de) 2003-06-15

Family

ID=17307684

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98941728T ATE241607T1 (de) 1997-09-04 1998-09-04 Epoxybernsteinsäureamid-derivate

Country Status (10)

Country Link
US (2) US6387908B1 (de)
EP (2) EP1342720A3 (de)
JP (1) JP4336039B2 (de)
AT (1) ATE241607T1 (de)
AU (1) AU8997898A (de)
DE (1) DE69815137T2 (de)
DK (1) DK1022276T3 (de)
ES (1) ES2201524T3 (de)
PT (1) PT1022276E (de)
WO (1) WO1999011640A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005515254A (ja) 2002-01-17 2005-05-26 スミスクライン ビーチャム コーポレーション カテプシンｋ阻害剤として有用なシクロアルキルケトアミド誘導体
US7056947B2 (en) * 2002-07-05 2006-06-06 Georgia Tech Research Corp. Aza-peptide epoxides
US8013014B2 (en) * 2002-07-05 2011-09-06 Georgia Tech Research Corporation Aza-peptide epoxides
EP1538142A4 (de) 2002-09-11 2006-07-26 Nippon Chemiphar Co Aminderivat
AU2004234235A1 (en) 2003-04-25 2004-11-11 Nippon Chemiphar Co., Ltd. Salt of (2s,3s)-3-[[(1s)-1-isobutoxymethyl-3-methylbutyl]carbamoyl]oxirane-2-carboxylic acid
CA2557631A1 (en) * 2004-02-18 2005-09-01 Georgia Tech Research Corporation Propenoyl hydrazides
WO2007038772A1 (en) 2005-09-28 2007-04-05 American Life Science Pharmaceuticals Novel drugs for dementia
EP2019688A2 (de) * 2006-05-22 2009-02-04 Velcura Therapeutics, Inc. Verwendung von cathepsin-k-antagonisten bei der knochenherstellung
US20100216875A1 (en) * 2006-12-20 2010-08-26 Gregory Hook Methods of treating alzheimer's disease
KR20100023948A (ko) 2007-06-08 2010-03-04 닛뽕 케미파 가부시키가이샤 뇌동맥류의 치료 또는 예방약
WO2009054454A1 (ja) 2007-10-24 2009-04-30 National University Corporation Tokyo Medical And Dental University カテプシン阻害剤を有効成分として含有するＴｏｌｌ様受容体のシグナル伝達の調整剤
WO2009065098A1 (en) * 2007-11-16 2009-05-22 Velcura Therapeutics, Inc. Use of cathepsin k antagonists in the treatment of bone cancer
JP2011241148A (ja) * 2008-09-08 2011-12-01 Nippon Chemiphar Co Ltd 医療用固形製剤
JP2012148978A (ja) * 2009-09-24 2012-08-09 Nippon Chemiphar Co Ltd 歯周病又は根尖性歯周炎の予防又は治療剤
BR112013029672A2 (pt) 2011-05-16 2017-01-17 Bayer Ip Gmbh uso de inibição da catepsina k para o tratamento e/ou profilaxia da hipertensão pulmonar e/ou insuficiência cardíaca
EP3986388A4 (de) * 2019-06-24 2024-02-21 Diverse Biotech, Inc. Cannabinoid-konjugatmoleküle

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5934711B2 (ja) 1975-09-03 1984-08-24 大正製薬株式会社 エポキシコハク酸エステル類の製法
JPS6059232B2 (ja) * 1977-03-03 1985-12-24 大正製薬株式会社 エポキシサクシニルアミノ酸誘導体
JPS6037104B2 (ja) * 1977-03-04 1985-08-24 大正製薬株式会社 エポキシコハク酸モノエステル誘導体
JPS5535012A (en) * 1978-09-02 1980-03-11 Taisho Pharmaceut Co Ltd Compound of epoxysuccinylamino acid
JPS55115878A (en) * 1979-02-27 1980-09-06 Taisho Pharmaceut Co Ltd Epoxysuccinic acid derivative
JPS5772913A (en) * 1980-10-22 1982-05-07 Nippon Chemiphar Co Ltd Remedy for cardiac infraction
JPS57169478A (en) * 1981-04-10 1982-10-19 Nippon Chemiphar Co Ltd Piperazine derivative
JPS58126879A (ja) * 1982-01-25 1983-07-28 Nippon Chemiphar Co Ltd 光学活性なピペラジン誘導体ならびに心筋梗塞の予防および治療剤
JPS6155509A (ja) 1984-08-27 1986-03-20 Dowa:Kk 気化バ−ナにおける燃焼促進装置
EP0269311A3 (de) 1986-11-17 1990-06-06 Merck & Co. Inc. Methoden zur Behandlung von Knochenleiden mittels Verabreichung von Cystein-Proteinaseinhibitoren
JP2515114B2 (ja) * 1987-01-23 1996-07-10 日本ケミフア株式会社 血小板凝集抑制剤
JP2515119B2 (ja) * 1987-04-20 1996-07-10 日本ケミフア株式会社 ピペラジン誘導体を含有する活性酸素産生抑制ならびに活性酸素除去作用を有する医薬組成物
JP2536754B2 (ja) * 1987-05-08 1996-09-18 日本ケミファ株式会社 ピペラジン誘導体
JPH0832698B2 (ja) * 1987-05-08 1996-03-29 日本ケミファ株式会社 ピペラジン誘導体
JP2554497B2 (ja) * 1987-06-10 1996-11-13 日本ケミファ株式会社 エポキシコハク酸誘導体を含有する医薬組成物
JPH02218610A (ja) 1989-02-21 1990-08-31 Toyo Jozo Co Ltd 骨疾患の予防および治療剤
US5068354A (en) * 1989-05-18 1991-11-26 Taisho Pharmaceutical Co., Ltd. Epoxysuccinic acid derivatives
JPH02304075A (ja) * 1989-05-18 1990-12-17 Taisho Pharmaceut Co Ltd エポキシコハク酸誘導体
JP2808877B2 (ja) * 1990-09-29 1998-10-08 大正製薬株式会社 エポキシスクシナム酸誘導体およびその中間体
CA2101417A1 (en) * 1992-08-14 1994-02-15 Ken-Ichi Saito Prophylactic and therapeutic treatment of alzheimer's disease
JPH06239835A (ja) 1992-12-25 1994-08-30 Mitsubishi Kasei Corp アミノケトン誘導体
JPH06336428A (ja) * 1993-05-27 1994-12-06 Takeda Chem Ind Ltd 免疫抑制剤
JPH07115985A (ja) * 1993-10-26 1995-05-09 Asahi Chem Ind Co Ltd 生理活性物質ａｍ４２９９、それらの製法ならびに用途
US5556853A (en) * 1993-10-29 1996-09-17 Takeda Chemical Industries, Ltd. Epoxysuccinic acid derivatives
JPH08104683A (ja) * 1993-10-29 1996-04-23 Takeda Chem Ind Ltd エポキシコハク酸誘導体
EP0763029A1 (de) * 1994-05-31 1997-03-19 Takeda Chemical Industries, Ltd. Epoxybernsteinsäurederivate, ihre herstellung und verwendung
JPH08104684A (ja) 1994-05-31 1996-04-23 Takeda Chem Ind Ltd エポキシコハク酸関連化合物
JPH0841043A (ja) * 1994-07-29 1996-02-13 Taisho Pharmaceut Co Ltd エポキシコハク酸誘導体
JPH0873352A (ja) * 1994-09-06 1996-03-19 Taisho Pharmaceut Co Ltd 高血圧治療剤
DE69624235T2 (de) 1995-03-31 2003-06-26 Nippon Chemiphar Co. Ltd., Tokio/Tokyo Derivate der epoxybernsteinsäure
JPH08325282A (ja) * 1995-03-31 1996-12-10 Nippon Chemiphar Co Ltd ビスホスホン酸誘導体
WO1997003060A1 (en) * 1995-07-13 1997-01-30 Senju Pharmaceutical Co., Ltd. Piperazine derivatives and use of the same
ES2193615T3 (es) * 1995-10-25 2003-11-01 Senju Pharma Co .nhibidor de la angiogenesis.
US5733911A (en) * 1996-01-26 1998-03-31 Hitachi Chemical Co., Ltd. Method for inducing death of neoplastic cells using piperazne derivatives
US6997899B2 (en) * 2002-12-17 2006-02-14 Boston Scientific Scimed, Inc, Rapid exchange dilation catheter for non-vascular applications

Also Published As

Publication number Publication date
US6387908B1 (en) 2002-05-14
PT1022276E (pt) 2003-10-31
DE69815137T2 (de) 2004-04-08
DE69815137D1 (de) 2003-07-03
EP1342720A2 (de) 2003-09-10
DK1022276T3 (da) 2003-09-29
EP1342720A3 (de) 2004-02-11
JP4336039B2 (ja) 2009-09-30
EP1022276A1 (de) 2000-07-26
EP1022276B1 (de) 2003-05-28
WO1999011640A1 (en) 1999-03-11
EP1022276A4 (de) 2001-12-12
US20020091131A1 (en) 2002-07-11
ES2201524T3 (es) 2004-03-16
AU8997898A (en) 1999-03-22
US6689785B2 (en) 2004-02-10

Similar Documents

Publication Publication Date Title
DK1022276T3 (da) Epoxysuccinamidderivater
DE69604714D1 (de) Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen
ATE52498T1 (de) Amidderivate.
NO308739B1 (no) Imidazolderivater samt medisinsk sammensetning og anti-HIV- sammensetning omfattende samme
DE69010232D1 (de) 2-(1-Piperazinyl)-4-phenylcycloalkanpyridin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
DE69228879D1 (de) Amidino-derivate und ihre verwendung als no-synthase inhibitoren
ES2141137T3 (es) Agentes terapeuticos para la enfermedad de parkinson.
HUP9802323A2 (hu) Pirimidinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyászati készítmények
PL368409A1 (en) Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a? receptor and their use as medicaments
ATE71090T1 (de) Heterocyclische verbindungen und deren herstellung und verwendung.
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
ATE74352T1 (de) Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
ES2012648A6 (es) Procedimiento para la preparacion de nuevos derivados de 1,4-benzoxazina y 1,4-benzotiazina.
TR200001239T2 (tr) Tiyazolidinediyon türevlerini hazırlama prosesi.
DE69512208D1 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
ATE137759T1 (de) S'-adenosyl-methionin-decarboxylase-inhibitoren
ATE166872T1 (de) Benzothiazol-derivate
DE69022564D1 (de) Benzoxazin- und Benzothiazin-Derivate und Herbizide, welche diese enthalten.
ATE47135T1 (de) Antikonvulsive mittel.
DE3873808D1 (de) Thiadiazolguanidine.
ATE53839T1 (de) 2,3-dihydro-3-phenyl-benzofuran-2-onacetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE181331T1 (de) Salmycine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IT1261958B (it) 2-(sostituite immino)-tiazolidine e procedimento per la loro preparazione e loro impiego quali antianginose e/o analgesiche
DE69106235D1 (de) N-Oxyimidsäurederivate.
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1022276

Country of ref document: EP